OBJECTIVE: Glycemia management in critical care is posing a challenge in frequent measuring and adequate insulin dose adjustment. In recent years, continuous glucose measurement has gained accuracy and reliability in outpatient and inpatient settings. The aim of this study was to assess the feasibility and accuracy of real-time continuous glucose monitoring (CGM) in ICU patients after major abdominal surgery. RESEARCH DESIGN AND METHODS: We included patients undergoing pancreatic surgery and solid organ transplantation (liver, pancreas, islets of Langerhans, kidney) requiring an ICU stay after surgery. We used a Dexcom G6 sensor, placed in the infraclavicular region, for real-time CGM. Arterial blood glucose measured by the amperometric principle (ABL 800; Radiometer, Copenhagen, Denmark) served as a reference value and for calibration. Blood glucose was also routinely monitored by a StatStrip bedside glucose meter. Sensor accuracy was assessed by mean absolute relative difference (MARD), bias, modified Bland-Altman plot, and surveillance error grid for paired samples of glucose values from CGM and acid-base analyzer (ABL). RESULTS: We analyzed data from 61 patients and obtained 1,546 paired glucose values from CGM and ABL. Active sensor use was 95.1%. MARD was 9.4%, relative bias was 1.4%, and 92.8% of values fell in zone A, 6.1% fell in zone B, and 1.2% fell in zone C of the surveillance error grid. Median time in range was 78%, with minimum (<1%) time spent in hypoglycemia. StatStrip glucose meter MARD compared with ABL was 5.8%. CONCLUSIONS: Our study shows clinically applicable accuracy and reliability of Dexcom G6 CGM in postoperative ICU patients and a feasible alternative sensor placement site.

1st Faculty of Medicine Charles University Prague Czech Republic

3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Anesthesiology Resuscitation and Intensive Care Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Diabetes Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Department of Laboratory Methods Institute for Clinical and Experimental Medicine Prague Czech Republic

Diabetes Research Institute Mills Peninsula Medical Center San Mateo CA

University of California San Francisco San Francisco CA

Diabetes Care. 2024 Jun 1;47(6):924-926. doi: 10.2337/dci24-0020. PubMed

Zobrazit více v PubMed

Galindo RJ, Aleppo G. Continuous glucose monitoring: the achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract 2020;170:108502. PubMed PMC

ElSayed NA, Aleppo G, Aroda VR, et al. .; American Diabetes Association . 16. Diabetes care in the hospital: Standards of Care in Diabetes–2023. Diabetes Care 2023;46(Suppl. 1):S267–S278 PubMed PMC

Blonde L, Umpierrez GE, Reddy SS, et al. . American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan–2022 Update. Endocr Pract 2022;28:923–1049 PubMed PMC

Korytkowski MT, Muniyappa R, Antinori-Lent K, et al. . Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2022;107:2101–2128 PubMed PMC

Galindo RJ, Umpierrez GE, Rushakoff RJ, et al. . Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline. J Diabetes Sci Technol 2020;14:1035–1064 PubMed PMC

Krinsley JS, Chase JG, Gunst J, et al. . Continuous glucose monitoring in the ICU: clinical considerations and consensus. Crit Care 2017;21:197. PubMed PMC

Galindo RJ, Aleppo G, Klonoff DC, et al. . Implementation of continuous glucose monitoring in the hospital: emergent considerations for remote glucose monitoring during the COVID-19 pandemic. J Diabetes Sci Technol 2020;14:822–832 PubMed PMC

U.S. Food and Drug Administration . Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring during the coronavirus disease 2019 (COVID-19) public health emergency (revised), 2020. Accessed 17 October 2022. Available from https://www.fda.gov/media/136290/download

Sadhu AR, Serrano IA, Xu J, et al. . Continuous glucose monitoring in critically ill patients with COVID-19: results of an emergent pilot study. J Diabetes Sci Technol 2020;14:1065–1073 PubMed PMC

Agarwal S, Mathew J, Davis GM, et al. . Continuous glucose monitoring in the intensive care unit during the COVID-19 pandemic. Diabetes Care 2021;44:847–849 PubMed PMC

Chow KW, Kelly DJ, Rieff MC, et al. . Outcomes and healthcare provider perceptions of real-time continuous glucose monitoring (rtCGM) in patients with diabetes and COVID-19 admitted to the ICU. J Diabetes Sci Technol 2021;15:607–614 PubMed PMC

Davis GM, Faulds E, Walker T, et al. . Remote continuous glucose monitoring with a computerized insulin infusion protocol for critically ill patients in a COVID-19 medical ICU: proof of concept. Diabetes Care 2021;44:1055–1058 PubMed PMC

Faulds ER, Boutsicaris A, Sumner L, et al. . Use of continuous glucose monitor in critically ill COVID-19 patients requiring insulin infusion: an observational study. J Clin Endocrinol Metab 2021;106:e4007–e4016 PubMed

Longo RR, Elias H, Khan M, Seley JJ. Use and accuracy of inpatient CGM during the COVID-19 pandemic: an observational study of general medicine and ICU patients. J Diabetes Sci Technol 2022;16:1136–1143 PubMed PMC

Nair BG, Dellinger EP, Flum DR, Rooke GA, Hirsch IB. A pilot study of the feasibility and accuracy of inpatient continuous glucose monitoring. Diabetes Care 2020;43:e168–e169 PubMed

Tripyla A, Herzig D, Joachim D, et al. . Performance of a factory-calibrated, real-time continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes Metab 2020;22:1678–1682 PubMed

Perez-Guzman MC, Duggan E, Gibanica S, et al. . Continuous glucose monitoring in the operating room and cardiac intensive care unit. Diabetes Care 2021;44:e50–e52 PubMed PMC

Dexcom. Dexcom G6 CGM system performance summary. Accessed 15 August 2023. Available from https://ie.provider.dexcom.com/dexcom-cgm

Herzig D, Suhner S, Roos J, et al. . Perioperative fully closed-loop insulin delivery in patients undergoing elective surgery: an open-label, randomized controlled trial. Diabetes Care 2022;45:2076–2083 PubMed

Krutkyte G, Roos J, Schuerch D, et al. . Fully closed-loop insulin delivery in patients undergoing pancreatic surgery. Diabetes Technol Ther 2023;25:206–211 PubMed PMC

Roos J, Schürch D, Frei A, et al. . Time requirements for perioperative glucose management using fully closed-loop versus standard insulin therapy: a proof-of-concept time-motion study. Diabet Med 2023;40:e15116 PubMed

van den Berghe G, Wouters P, Weekers F, et al. . Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367 PubMed

Finfer S, Chittock DR, Su SY, et al. .; NICE-SUGAR Study Investigators . Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283–1297 PubMed

de Vries FEE, Gans SL, Solomkin JS, et al. . Meta-analysis of lower perioperative blood glucose target levels for reduction of surgical-site infection. Br J Surg 2017;104:e95–e105 PubMed

Preiser J-C, Devos P, Ruiz-Santana S, et al. . A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009;35:1738–1748 PubMed

Heinemann L. Interferences with CGM systems: practical relevance? J Diabetes Sci Technol 2022;16:271–274 PubMed PMC

Franeková J, Protuš M, Kieslichová E, et al. . Changes in sepsis biomarkers after immunosuppressant administration in transplant patients. Mediators Inflamm 2021;2021:8831659. PubMed PMC

Werner KT, Mackey PA, Castro JC, Carey EJ, Chakkera HA, Cook CB. Hyperglycemia during the immediate period following liver transplantation. Future Sci OA 2016;2:fsoa-2015-0010. PubMed PMC

Saracoglu A, Saracoglu KT. Coagulopathy during liver transplantation. J Anaesthesiol Clin Pharmacol 2018;34:289–295 PubMed PMC

Klonoff DC, Umpierrez GE, Rice MJ. A milestone in point of care capillary blood glucose monitoring of critically ill hospitalized patients. J Diabetes Sci Technol 2018;12:1095–1100 PubMed PMC

Klonoff DC, Lias C, Vigersky R, et al. .; Error Grid Panel . The surveillance error grid. J Diabetes Sci Technol 2014;8:658–672 PubMed PMC

Parkes JL, Slatin SL, Pardo S, Ginsberg BH. A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose. Diabetes Care 2000;23:1143–1148 PubMed

Clarke WL, Cox D, Gonder-Frederick LA, Carter W, Pohl SL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622–628 PubMed

Kovatchev BP, Wakeman CA, Breton MD, et al. .. Computing the surveillance error grid analysis: procedure and examples. J Diabetes Sci Technol 2014;8:673–84 PubMed PMC

International Organization for Standardization . ISO 15197:2013 In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. Geneva, Switzerland, International Organization for Standardization, 2013

Voglová Hagerf B, Protuš M, Németová L, et al. . Alternative site of RT-CGM sensor application for abdominal surgery in the infraclavicular region. J Diabetes Sci Technol 2023;17:1728–1730 PubMed PMC

U.S. Food and Drug Administration. Blood glucose monitoring test systems for prescription point-of-care use guidance for industry and Food and Drug Administration staff . U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. Accessed 15 August 2023. Available from https://www.fda.gov/regulatory-information/search-fda-guidance-documents/blood-glucose-monitoring-test-systems-prescription-point-care-use

Liang Y, Wanderer J, Nichols JH, Klonoff D, Rice MJ. Blood gas analyzer accuracy of glucose measurements. Mayo Clin Proc 2017;92:1030–1041 PubMed